The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...

Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...

President Donald Trump is now "in a race" against the coronavirus, the CEO of biotechnology company Regeneron said Friday after the drug maker provided a dose of its experimental antibody treatment to ...

LONDON - Initial results from a large study in the U.K. found that an antibody drug reduced death in hospitalized COVID-19 patients who faced the highest risk from the virus. The study was led by the ...

Trump received an experimental Regeneron antibody cocktail, remdesivir, dexamethasone, zinc, vitamin D and more during just four days in hospital. He later called the antibody treatment “a cure.” The ...

President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this ...